Upgrade to SI Premium - Free Trial

Lam Research Corporation Reports Financial Results for the Quarter Ended June 28, 2015

July 29, 2015 4:05 PM

FREMONT, CA -- (Marketwired) -- 07/29/15 -- Lam Research Corp. (NASDAQ: LRCX) today announced financial results for the quarter ended June 28, 2015.

Highlights for the June 2015 quarter were as follows:

                                                                            
                                                                            
  Financial Highlights for the Quarters Ended June 28, 2015 and March 29,   
                                    2015                                    
    (in thousands, except per-share data, percentages, and basis points)    
                                                                            
                                 U.S. GAAP                                  
--------------------------------------------------------------------------- 
                                                                    Change  
                                           June 2015  March 2015     Q/Q    
                                          ----------  ----------  --------- 
                                                                            
Revenue                                   $1,481,370  $1,393,333         +6%
Gross margin as percentage of revenue           43.3%       43.1%    +20bps 
Operating margin as percentage of revenue       12.9%       17.2%  -430 bps 
Diluted EPS                               $     0.74  $     1.16        -36%
                                                                            
                                  Non-GAAP                                  
--------------------------------------------------------------------------- 
                                                                    Change  
                                           June 2015  March 2015     Q/Q    
                                          ----------  ----------  --------- 
                                                                            
Revenue                                   $1,481,370  $1,393,333         +6%
Gross margin as percentage of revenue           45.5%       44.7%   +80 bps 
Operating margin as percentage of revenue       21.6%       19.9%  +170 bps 
Diluted EPS                               $     1.50  $     1.40         +7%
                                                                            

GAAP Financial Results

For the June 2015 quarter, revenue was $1,481.4 million, gross margin was $641.5 million, or 43.3% of revenue, operating expenses were $450.5 million, operating margin was 12.9% of revenue, and net income was $131.3 million, or $0.74 per diluted share on a GAAP basis. This compares to revenue of $1,393.3 million, gross margin of $600.6 million, or 43.1% of revenue, operating expenses of $360.6 million, operating margin of 17.2% of revenue, and net income of $206.3 million, or $1.16 per diluted share, for the quarter ended March 29, 2015 (the "March 2015 quarter"). The June 2015 operating expenses, operating margin, net income and income per diluted share were negatively impacted by a goodwill impairment charge of $79.4 million. In addition, gross margin, operating margin, net income and income per diluted share were negatively impacted by an impairment charge related to a long-lived asset of $9.8 million.

Non-GAAP Financial Results

For the June 2015 quarter, non-GAAP gross margin was $673.8 million or 45.5% of revenue, non-GAAP operating expenses were $354.5 million, non-GAAP operating margin was 21.6% of revenue, and non-GAAP net income was $260.0 million, or $1.50 per diluted share. This compares to non-GAAP gross margin of $622.2 million or 44.7% of revenue, non-GAAP operating expenses of $345.0 million, non-GAAP operating margin of 19.9% of revenue, and non-GAAP net income of $244.9 million, or $1.40 per diluted share for the March 2015 quarter.

"Lam posted record June quarter results and concluded the strongest fiscal year in our history by delivering over $5 billion in both shipments and revenue and $1 billion in operating income for the first time," said Martin Anstice, Lam Research's president and chief executive officer. "The inflection driven expansion in our served available market over the next several years combined with our enduring focus on supporting our customers' long term success, creates exciting opportunity. Our technology and productivity leadership, our execution discipline and our model of collaboration, we believe, position us for continued outperformance."

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investment balances increased to $4.2 billion at the end of the June 2015 quarter compared to $4.1 billion at the end of the March 2015 quarter. This increase was primarily the result of approximately $292.1 million in cash flows from operating activities which was partially offset by approximately $74.3 million of treasury stock repurchases, including net share settlement on employee stock-based compensation; approximately $63.1 million of capital expenditures; and approximately $28.7 million of dividends paid to stockholders during the June 2015 quarter.

Deferred revenue and profit balances at the end of June 2015 quarter increased to $518.1 million and $322.1 million, respectively, as compared to $485.2 million and $303.3 million at the end of the March 2015 quarter, respectively. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $164.4 million as of June 28, 2015.

Geographic Distribution

The geographic distribution of shipments and revenue during the June 2015 quarter is shown in the following table:

                                                                            
                   Region                       Shipments        Revenue    
-------------------------------------------- --------------- ---------------
Korea                                                    23%       28%      
Taiwan                                                   24%       19%      
China                                                    12%       17%      
United States                                            13%       14%      
Japan                                                    20%       14%      
Europe                                                    4%        4%      
Southeast Asia                                            4%        4%      
                                                                            

Outlook

For the September 2015 quarter, Lam is providing the following guidance:

                                                                            
                                      Reconciling                           
                      GAAP               Items             Non-GAAP         
          ------------------------------------------------------------------
Shipments $1.58 Billion +/-$75 Million     -     $1.58 Billion+/-$75 Million
Revenue   $1.60 Billion +/-$75 Million     -     $1.60 Billion+/-$75 Million
Gross                                                                       
 margin       44.2%     +/-     1%    $21 Million    45.5%    +/-     1%    
Operating                                                                   
 margin       20.2%     +/-     1%    $37 Million    22.5%    +/-     1%    
Net income                                                                  
 per                                                                        
 diluted                                                                    
 share        $1.46     +/-   $0.10   $38 Million    $1.70    +/-   $0.10   
Diluted                                                                     
 share                                                                      
 count             177 Million                           174 Million        
                                                                            

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the June 2015 and March 2015 quarters exclude amortization related to intangible assets acquired in the Novellus transaction, acquisition-related inventory fair value impact, restructuring impacts, the amortization of notes discounts, tax expense (benefit) of non-GAAP items, and net income tax benefit on successful resolution of certain tax matters. Additionally, the June 2015 quarter non-GAAP results exclude long-lived asset impairment, goodwill impairment, and additional accrual for certain tax matters.

Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's web site at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, the anticipated revenue from shipments to Japanese customers, our ability to continue to successfully execute our growth strategy, our ability to continue to successfully collaborate closely with and to support our customers and their long term success, our ability to achieve market growth and share gains at key inflections, our ability to continue to outperform, our ability to deliver growth and value for our customers and our stockholders, the extent of inflection driven expansion in our served available market, and our guidance for shipments, revenue, gross margin, operating margin, earnings per share, and diluted earnings per share and share count. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy; the strength of the financial documents filed by us with the Securities and Exchange Commission, including specifically our report on Form 10-K for the year ended June 29, 2014 and Forms 10-Q for the quarters ended September 28, 2014, December 28, 2014 and March 29, 2015. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

About Lam Research

Lam Research Corp. (NASDAQ: LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading deposition, etch, strip, and wafer cleaning solutions helps customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, and more power-efficient chips. Through collaboration, continuous innovation, and delivering on commitments, Lam is transforming atomic-scale engineering and enabling its customers to shape the future of technology. Based in Fremont, Calif., Lam Research is a NASDAQ-100 Index ® and S&P 500 ® company whose common stock trades on the NASDAQ ® Global Select Market™ under the symbol LRCX. For more information, please visit http://www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

                                                                            
                                                                            
                          LAM RESEARCH CORPORATION                          
              CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS               
           (in thousands, except per share data and percentages)            
                                                                            
                         Three Months Ended           Twelve Months Ended   
                ----------------------------------- ----------------------- 
                  June 28,   March 29,    June 29,    June 28,    June 29,  
                    2015        2015        2014        2015        2014    
                ----------- ----------- ----------- ----------- ----------- 
                (unaudited) (unaudited) (unaudited) (unaudited)     (1)     
Revenue         $ 1,481,370 $ 1,393,333 $ 1,248,797 $ 5,259,312 $ 4,607,309 
                                                                            
  Cost of goods                                                             
   sold             839,832     792,731     691,761   2,974,976   2,599,828 
                ----------- ----------- ----------- ----------- ----------- 
    Gross                                                                   
     margin         641,538     600,602     557,036   2,284,336   2,007,481 
    Gross                                                                   
     margin as                                                              
     a percent                                                              
     of revenue        43.3%       43.1%       44.6%       43.4%       43.6%
Research and                                                                
 development        221,675     217,865     185,449     825,242     716,471 
Selling,                                                                    
 general and                                                                
 administrative     149,384     142,772     155,737     591,611     613,341 
Goodwill                                                                    
 impairment          79,444           -           -      79,444           - 
                ----------- ----------- ----------- ----------- ----------- 
    Total                                                                   
     operating                                                              
     expenses       450,503     360,637     341,186   1,496,297   1,329,812 
                ----------- ----------- ----------- ----------- ----------- 
    Operating                                                               
     income         191,035     239,965     215,850     788,039     677,669 
    Operating                                                               
     margin as                                                              
     a percent                                                              
     of revenue        12.9%       17.2%       17.3%       15.0%       14.7%
Gain on sale of                                                             
 real estate              -           -      83,090           -      83,090 
Other expense,                                                              
 net                (20,353)    (11,389)     (9,442)    (47,189)    (37,396)
                ----------- ----------- ----------- ----------- ----------- 
    Income                                                                  
     (loss)                                                                 
     before                                                                 
     income                                                                 
     taxes          170,682     228,576     289,498     740,850     723,363 
Income tax                                                                  
 expense                                                                    
 (benefit)           39,411      22,291      56,103      85,273      91,074 
                ----------- ----------- ----------- ----------- ----------- 
    Net income  $   131,271 $   206,285 $   233,395 $   655,577 $   632,289 
                =========== =========== =========== =========== =========== 
Net income per                                                              
 share:                                                                     
  Basic net                                                                 
   income per                                                               
   share        $      0.83 $      1.30 $      1.44 $      4.11 $      3.84 
                =========== =========== =========== =========== =========== 
  Diluted net                                                               
   income per                                                               
   share        $      0.74 $      1.16 $      1.35 $      3.70 $      3.62 
                =========== =========== =========== =========== =========== 
Number of                                                                   
 shares used in                                                             
 per share                                                                  
 calculations:                                                              
  Basic             158,590     158,992     162,215     159,629     164,741 
                =========== =========== =========== =========== =========== 
  Diluted           176,575     177,531     173,345     177,067     174,503 
                =========== =========== =========== =========== =========== 
Cash dividend                                                               
 declared per                                                               
 share          $      0.30 $      0.18 $      0.18 $      0.84 $      0.18 
                =========== =========== =========== =========== =========== 
                                                                            
(1) Derived from audited financial statements                               
                                                                            
                                                                            
                                                                            
                          LAM RESEARCH CORPORATION                          
                    CONDENSED CONSOLIDATED BALANCE SHEETS                   
                               (in thousands)                               
                                                                            
                                           June 28,   March 29,    June 29, 
                                             2015        2015        2014   
                                         ----------- ----------- -----------
                                         (unaudited) (unaudited)     (1)    
ASSETS                                                                      
Cash and cash equivalents                $ 1,501,539 $ 1,635,636 $ 1,452,677
Short-term investments                     2,574,947   2,313,495   1,612,967
Accounts receivable, net                   1,093,582   1,046,800     800,616
Inventories                                  943,346     919,679     740,503
Other current assets                         157,435     145,357     176,899
                                         ----------- ----------- -----------
  Total current assets                     6,270,849   6,060,967   4,783,662
Property and equipment, net                  621,418     579,824     543,496
Restricted cash and investments              170,969     164,300     146,492
Goodwill and intangible assets             2,115,649   2,242,977   2,360,303
Other assets                                 185,763     190,473     159,353
                                         ----------- ----------- -----------
  Total assets                           $ 9,364,648 $ 9,238,541 $ 7,993,306
                                         =========== =========== ===========
                                                                            
LIABILITIES AND STOCKHOLDERS' EQUITY                                        
Current portion of long-term debt,                                          
 convertible notes, and capital leases   $ 1,359,650 $   518,267 $   520,686
Other current liabilities                  1,271,711   1,216,729   1,061,315
                                         ----------- ----------- -----------
  Total current liabilities                2,631,361   1,734,996   1,582,001
                                                                            
Long-term debt and capital leases        $ 1,001,382 $ 1,831,094 $   817,202
Income taxes payable                         202,930     205,536     258,357
Other long-term liabilities                  184,023     189,291     122,662
                                         ----------- ----------- -----------
  Total liabilities                      $ 4,019,696 $ 3,960,917 $ 2,780,222
                                         =========== =========== ===========
                                                                            
Senior convertible notes                     241,808     180,569     183,349
                                                                            
Stockholders' equity (2)                   5,103,144   5,097,055   5,029,735
                                         ----------- ----------- -----------
  Total liabilities and stockholders'                                       
   equity                                $ 9,364,648 $ 9,238,541 $ 7,993,306
                                         =========== =========== ===========
                                                                            
(1) Derived from audited financial statements                               
                                                                            
(2) Common shares issued and outstanding were 158,531 as of June 28, 2015,  
    158,485 shares as of March 29, 2015, and 162,350 shares as of June 29,  
    2014.                                                                   
                                                                            
                                                                            
                                                                            
                          LAM RESEARCH CORPORATION                          
              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS               
                               (in thousands)                               
                                                                            
                         Three Months Ended           Twelve Months Ended   
                ----------------------------------- ----------------------- 
                  June 28,   March 29,    June 29,    June 28,    June 29,  
                    2015        2015        2014        2015        2014    
                ----------- ----------- ----------- ----------- ----------- 
                (unaudited) (unaudited) (unaudited) (unaudited)     (1)     
CASH FLOWS FROM                                                             
 OPERATING                                                                  
 ACTIVITIES:                                                                
Net income      $   131,271 $   206,285 $   233,395 $   655,577 $   632,289 
Adjustments to                                                              
 reconcile net                                                              
 income to net                                                              
 cash provided                                                              
 by operating                                                               
 activities:                                                                
  Depreciation                                                              
   and                                                                      
   amortization      70,177      70,322      71,115     277,920     292,254 
  Deferred                                                                  
   income taxes      (2,694)      1,739      (4,104)      5,551       7,537 
  Impairment of                                                             
   long-lived                                                               
   assets             9,821           -           -       9,821      11,632 
  Equity-based                                                              
   compensation                                                             
   expense           39,734      32,948      33,085     135,354     103,700 
  Income tax                                                                
   benefit                                                                  
   (expense) on                                                             
   equity-based                                                             
   compensation                                                             
   plans             (2,124)      2,438       6,269      11,316       5,973 
  Excess tax                                                                
   (benefit)                                                                
   expense on                                                               
   equity-based                                                             
   compensation                                                             
   plans              1,809      (2,204)     (6,361)    (11,398)     (6,065)
  Amortization                                                              
   of note                                                                  
   discounts                                                                
   and issuance                                                             
   costs             11,023       9,409       9,002      37,550      35,482 
  Gain on sale                                                              
   of business            -           -           -      (7,431)          - 
  Gain on sale                                                              
   of real                                                                  
   estate                 -           -     (83,090)          -     (83,090)
  Goodwill                                                                  
   impairment        79,444           -           -      79,444           - 
  Other, net          3,621       1,902       8,241      12,656      12,669 
  Changes in                                                                
   operating                                                                
   asset and                                                                
   liabilities:     (50,016)   (131,802)    (21,661)   (420,857)   (295,332)
                ----------- ----------- ----------- ----------- ----------- 
    Net cash                                                                
     provided                                                               
     by                                                                     
     operating                                                              
     activities     292,066     191,037     245,891     785,503     717,049 
                ----------- ----------- ----------- ----------- ----------- 
                                                                            
CASH FLOWS FROM                                                             
 INVESTING                                                                  
 ACTIVITIES:                                                                
Capital                                                                     
 expenditures                                                               
 and intangible                                                             
 assets             (63,133)    (31,898)    (41,764)   (198,265)   (145,503)
Cash paid for                                                               
 business                                                                   
 acquisition              -           -     (11,839)     (1,137)    (30,227)
Net purchases                                                               
 of available-                                                              
 for-sale                                                                   
 securities        (278,379)   (359,416)   (155,035)   (949,740)   (283,966)
Proceeds from                                                               
 sale of                                                                    
 business                 -           -           -      41,212           - 
Purchase of                                                                 
 other                                                                      
 investment               -      (2,500)          -      (2,500)          - 
Repayments of                                                               
 notes                                                                      
 receivable               -           -           -       3,978      10,000 
Proceeds from                                                               
 sale of assets           -           -     134,762           -     156,397 
Transfer of                                                                 
 restricted                                                                 
 cash and                                                                   
 investments          1,056        (822)       (637)        356      28,085 
                ----------- ----------- ----------- ----------- ----------- 
    Net cash                                                                
     used for                                                               
     investing                                                              
     activities    (340,456)   (394,636)    (74,513) (1,106,096)   (265,214)
                ----------- ----------- ----------- ----------- ----------- 
                                                                            
CASH FLOWS FROM                                                             
 FINANCING                                                                  
 ACTIVITIES:                                                                
Principal                                                                   
 payments on                                                                
 long-term debt                                                             
 and capital                                                                
 lease                                                                      
 obligations           (615)       (119)       (739)     (1,515)     (1,658)
Proceeds from                                                               
 issuance of                                                                
 long-term                                                                  
 debt, net                                                                  
 issuance costs                                                             
 and captial                                                                
 lease                                                                      
 obligations            345     991,880           -     992,225           - 
Excess tax                                                                  
 benefit                                                                    
 (expense) on                                                               
 equity-based                                                               
 compensation                                                               
 plans               (1,809)      2,204       6,361      11,398       6,065 
Treasury stock                                                              
 purchases          (74,339)   (124,943)    (40,249)   (573,240)   (244,859)
Dividends paid      (28,714)    (28,724)          -    (116,059)          - 
Reissuances of                                                              
 treasury stock                                                             
 related to                                                                 
 employee stock                                                             
 purchase plan       16,950      14,934      14,597      48,803      42,926 
Proceeds from                                                               
 issuance of                                                                
 common stock         1,285       7,403       8,657      17,520      34,791 
Other                  (660)          -           -        (660)          - 
                ----------- ----------- ----------- ----------- ----------- 
    Net cash                                                                
     provided                                                               
     by (used                                                               
     for)                                                                   
     financing                                                              
     activities     (87,557)    862,635     (11,373)    378,472    (162,735)
                ----------- ----------- ----------- ----------- ----------- 
Effect of                                                                   
 exchange rate                                                              
 changes on                                                                 
 cash                 1,850      (4,675)        371      (9,017)      1,104 
Net increase                                                                
 (decrease) in                                                              
 cash and cash                                                              
 equivalents       (134,097)    654,361     160,376      48,862     290,204 
Cash and cash                                                               
 equivalents at                                                             
 beginning of                                                               
 period           1,635,636     981,275   1,292,301   1,452,677   1,162,473 
                ----------- ----------- ----------- ----------- ----------- 
Cash and cash                                                               
 equivalents at                                                             
 end of period  $ 1,501,539 $ 1,635,636 $ 1,452,677 $ 1,501,539 $ 1,452,677 
                =========== =========== =========== =========== =========== 
                                                                            
(1) Derived from audited financial statements                               
                                                                            
                                                                            
                                                                            
                         Non-GAAP Financial Summary                         
           (in thousands, except percentages and per share data)            
                                (unaudited)                                 
                                                                            
                                                Three Months   Three Months 
                                                   Ended          Ended     
                                               -------------  ------------- 
                                                  June 28,      March 29,   
                                                    2015           2015     
                                               -------------  ------------- 
                                                                            
Revenue                                        $   1,481,370  $   1,393,333 
Gross margin                                   $     673,837  $     622,196 
Gross margin as percentage of revenue                   45.5%          44.7%
Operating expenses                             $     354,542  $     345,049 
Operating income                               $     319,295  $     277,147 
Operating margin as a percentage of revenue             21.6%          19.9%
Net income                                     $     260,023  $     244,911 
Net income per diluted share                   $        1.50  $        1.40 
Shares used in per share calculation - diluted       173,641        174,471 
                                                                            
                                                                            
                                                                            
 Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP
       number of dilutive shares to Non-GAAP number of dilutive shares      
                    (in thousands, except per share data)                   
                                 (unaudited)                                
                                                                            
                                                 Three Months  Three Months 
                                                    Ended         Ended     
                                                ------------- ------------- 
                                                   June 28,     March 29,   
                                                     2015          2015     
                                                ------------- ------------- 
U.S. GAAP net income                            $     131,271 $     206,285 
Pre-tax non-GAAP items:                                                     
  Amortization related to intangible assets                                 
   acquired in Novellus transaction - cost of                               
   goods sold                                          21,286        21,286 
  Acquisition-related inventory fair value                                  
   impact - cost of goods sold                          1,192           308 
  Impairment of long lived asset - cost of goods                            
   sold                                                 9,821             - 
  Amortization related to intangible assets                                 
   acquired in Novellus transaction - operating                             
   expenses                                            16,083        16,083 
  Restructuring charges/(benefits) - operating                              
   expenses                                               434          (495)
  Goodwill impairment - operating expenses             79,444             - 
  Amortization of note discounts - other                                    
   expense, net                                         9,019         8,749 
Net tax benefit on non-GAAP items                      (9,605)       (7,181)
Net income tax expense (benefit) on resolution                              
 or additional accrual for certain tax matters          1,078          (124)
                                                ------------- ------------- 
Non-GAAP net income                             $     260,023 $     244,911 
                                                ============= ============= 
Non-GAAP net income per diluted share           $        1.50 $        1.40 
                                                ============= ============= 
U.S. GAAP number of shares used for diluted per                             
 share calculation                                    176,575       177,531 
Effect of convertible note hedge                       (2,934)       (3,060)
                                                ------------- ------------- 
Non-GAAP number of shares used for diluted per                              
 share calculation                                    173,641       174,471 
                                                ============= ============= 
                                                                            
                                                                            
                                                                            
 Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating 
  Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income  
                                (unaudited)                                 
                                                                            
                   Three Months  Three Months   Three Months   Three Months 
                       Ended         Ended         Ended          Ended     
                   ------------  ------------  -------------  ------------- 
                     June 28,      March 29,    December 28,  September 28, 
                       2015          2015           2014           2014     
                   ------------  ------------  -------------  ------------- 
U.S. GAAP gross                                                             
 margin            $    641,538  $    600,602  $     536,657  $     505,539 
Pre-tax non-GAAP                                                            
 items:                                                                     
  Amortization                                                              
   related to                                                               
   intangible                                                               
   assets acquired                                                          
   in Novellus                                                              
   transaction -                                                            
   cost of goods                                                            
   sold                  21,286        21,286         21,286         20,893 
  Acquisition-                                                              
   related                                                                  
   inventory fair                                                           
   value impact -                                                           
   cost of goods                                                            
   sold                   1,192           308          2,101              - 
  Impairment of                                                             
   long lived                                                               
   asset - cost of                                                          
   goods sold             9,821             -              -              - 
  Costs associted                                                           
   with                                                                     
   rationalization                                                          
   of certain                                                               
   product                                                                  
   configurations                                                           
   - cost of goods                                                          
   sold                       -             -              -          1,600 
                   ------------  ------------  -------------  ------------- 
Non-GAAP gross                                                              
 margin            $    673,837  $    622,196  $     560,044  $     528,032 
                   ============  ============  =============  ============= 
U.S. GAAP gross                                                             
 margin as a                                                                
 percentage of                                                              
 revenue                   43.3%         43.1%          43.6%          43.9%
Non-GAAP gross                                                              
 margin as a                                                                
 percentage of                                                              
 revenue                   45.5%         44.7%          45.4%          45.8%
U.S. GAAP                                                                   
 operating                                                                  
 expenses          $    450,503  $    360,637  $     347,916  $     337,241 
Pre-tax non-GAAP                                                            
 items:                                                                     
  Amortization                                                              
   related to                                                               
   intangible                                                               
   assets acquired                                                          
   in Novellus                                                              
   transaction -                                                            
   operating                                                                
   expenses             (16,083)      (16,083)       (16,083)       (16,083)
  Restructuring                                                             
   (charges)/benef                                                          
   its - operating                                                          
   expenses                (434)          495         (1,620)             - 
  Goodwill                                                                  
   impairment -                                                             
   operating                                                                
   expenses             (79,444)            -              -              - 
                   ------------  ------------  -------------  ------------- 
Non-GAAP operating                                                          
 expenses          $    354,542  $    345,049  $     330,213  $     321,158 
                   ============  ============  =============  ============= 
Non-GAAP operating                                                          
 income            $    319,295  $    277,147  $     229,831  $     206,874 
                   ============  ============  =============  ============= 
GAAP operating                                                              
 margin as percent                                                          
 of revenue                12.9%         17.2%          15.3%          14.6%
Non-GAAP operating                                                          
 margin as a                                                                
 percent of                                                                 
 revenue                   21.6%         19.9%          18.7%          18.0%
   Lam Research Corporation Contacts:Audrey CharlesInvestor Relationsphone: 510-572-1615e-mail: [email protected]

Source: Lam Research Corporation

Categories

Press Releases

Next Articles